19,869
Views
98
CrossRef citations to date
0
Altmetric
Research Articles

In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria

, , &
Pages 3263-3276 | Received 07 Apr 2020, Accepted 24 Apr 2020, Published online: 14 May 2020

References

  • Aanouz, I., Belhassan, A., Khatabi, K. E., Lakhlifi, T., Idrissi, M. E., & Bouachrine, M. (2020). Moroccan Medicinal plants as inhibitors of COVID-19: Computational investigations. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2020.1758790.
  • Abdelouahid, D. E., & Bekhechi, C. (2002). Pouvoir antimicrobien de l’huile essentielle d’Ammoïdes verticillata (Nûnkha). Biologie et Santé, 4, 91–100.
  • Aronov, A. M. (2005). Predictive in silico modeling for hERG channel blockers. Drug Discovery Today, 10(2), 149–155. doi:10.1016/S1359-6446(04)03278-7
  • Avesina, A. (1985). Law in medecine (2nd éd.). Soroush Press. pp 187.
  • Awan, F., Obaid, A., Ikram, A., & Janjua, H. (2017). Mutation-structure-function relationship based integrated strategy reveals the potential impact of deleterious missense mutations in autophagy related proteins on hepatocellular carcinoma (HCC): A comprehensive informatics approach. International Journal of Molecular Sciences, 18(1), 139. doi:10.3390/ijms18010139
  • Bekhechi, C. (2002). Analyse de l’huile essentielle d’Ammoïdes verticillata (Nûnkha) de la région de Tlemcen et étude de son pouvoir antimicrobien. Mémoire de Magister, option Biologie Moléculaire et Cellulaire, université Abou Bah Belkaïd.
  • Bekhechia, C., Brice Botib, J., Atik Bekkaraa, F., Eddine Abdelouahida, D., Casanovab, J., & Tomib, F. (2010). Isothymol in Ajowan essential oil. Naturel Product Communication, 5(7), 71107–71110.
  • Bhargava, H. (1961). Anoxidative effect of Ajowan in a model system. Journal of the American Oil Chemists' Society, 72(10), 1215–1218. in Mehta, R. L., & Zayas, J. F. (1995). doi:10.1007/BF02540992
  • Boopathy, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics. doi:10.1080/07391102.2020.1758788
  • Boskabady, M. H., & Shaikhi, J. (2000). Inhibitory effect of Carum copticum on histamine (H1) receptors ofisolated guinea-pig. Tracheal chains. Journal of Ethnopharmacology, 69(3), 217–227. doi:10.1016/S0378-8741(99)00116-6
  • Clément, G., &Slenzka, K. (Eds.). (2006). Fundamentals of space biology: research on cells, animals, and plants in space. Springer Science & Business Media. pp. 18.
  • Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717. doi:10.1038/srep42717
  • Didierjean, C., & Tête-Favier, F. (2016). Introduction to protein science. architecture, function and genomics. 3rd ed. Arthur M. Lesk. Oxford University Press. pp. 466. Paperback. Price GBP 39.99. ISBN 9780198716846.
  • Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20(10–11), 647–671. doi:10.1007/s10822-006-9087-6
  • Dubey, N. K., & Mishra, A. K. (1990). Evaluation of some essential oils against dermatophytes. T Indian Drugs, 27, 529–531.
  • Egan, W. J., Merz, K. M., & Baldwin, J. J. (2000). Prediction of drug absorption using multivariate statistics. Journal of Medicinal Chemistry, 43(21), 3867–3877. doi:10.1021/jm000292e
  • Elfiky, A. A., & Azzam, E. B. (2020). Novel Guanosine Derivatives against MERS CoVpolymerase: An in silico perspective. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2020.1758789.
  • Elmezayen, A. D., Al-Obaidi, A., Tegin Şahin, A., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19):in silico screening of known drugs againstcoronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2020.1758791
  • Enayatkhani, M., Hasaniazad, M., Faezi, S., Guklani, H., Davoodian, P., Ahmadi, N., Ali Einakian, M., Karmostaji, A., & Ahmadi, K. (2020). Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An in silico study. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2020.1756411
  • Ghose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1999). A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. Journal of Combinatorial Chemistry, 1(1), 55–68. doi:10.1021/cc9800071
  • Grosjean, N. (2004). Huiles essentielles: Se soigner par l’aromathérapie. Ed. Eyrolles, pp 98.
  • Guastalegname, M., & Vallone, A. (2020). Could chloroquine/hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment? Clinical Infectious Diseases, [Published online ahead of print, 2020 Mar 24]. doi:10.1093/cid/ciaa321
  • Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of thehuman severe acute respiratory syndromecoronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2020.1751300
  • Hasan, A., Ahamad Paray, B., Hussain, A., Ali Qadir, F., Attar, F., Mohammad Aziz, F., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., Shahpasand, K., Akbar Saboury, A., & Falahati, M. (2020). A review on the cleavage priming of the spike protein on coronavirusby angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2020.1754293
  • Higley, C., & Higley, A. (2005). Quick reference guide for using essential oils. 9th ed. Abundant Health. Orange, pp. 6–10.
  • Hopkins, C. (2020). “Loss of sense of smell as marker of COVID-19 infection”. Ear, Nose and Throat surgery body of United Kingdom. Retrieved 28 March 2020.
  • Hui, D S., Azhar, I. E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., Zumla, A., & Petersen, E. (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases, 91, 264–266. doi:10.1016/j.ijid.2020.01.009
  • HyperChem v8. (2009). Molecular Modelling System, Hypercube Inc., 1115 NW 4th Street, Gainesville, FL 32601, USA.
  • Jabeer Khan, R., Jha, R. K., Muluneh Amera, G., Jain, M., Singh, E., Pathak, A., Prabha Singh, R., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identifypromising inhibitors against 3C-like proteinase and 2-O-ribosemethyltransferase. Journal of Biomolecular Structure and Dynamics, 20 April. doi: 10.1080/07391102.2020.1753577
  • Joshi, B. S., Ramanujam, S., & Sahena, M. B. L. (1963). Improvement of some essential ou bearing spice plants. Bull. Regional Res. Lab. Ja, 1, 94–100.
  • Kambouche, N., & El-Abed, D. (2003). Composition of the volatile oil from the aerial parts of Trachyspermum ammi (L.) Sprague from Oran (Algeria). Journal of Essential Oil Research, 15(1), 39–40. doi:10.1080/10412905.2003.9712259
  • Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2viaintegrated computational approach. Journal of Biomolecular Structure and Dynamics. doi:10.1080/07391102.2020.1751298
  • Lagunin, A., Stepanchikova, A., Filimonov, D., & Poroikov, V. (2000). PASS: 2000. prediction of activity spectra for biologically active substances. Bioinformatics, 16(8), 747–748. doi:10.1093/bioinformatics/16.8.747
  • Lawrence, B. M. (2006). Progress in essential oils. Perfumer & Flavorist, 31, 63–64.
  • Li, F., Li, W., Farzan, M., et., & Harrison, S. C. (2005). Structure of SARS Coronavirus spike receptor-binding domain complexed with receptor. Science, 309 (5742), 1864–1868. doi:10.1126/science.1116480
  • Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26. doi:10.1016/j.addr.2012.09.019
  • López-Blanco, J. R., Aliaga, J. I., Quintana-Ortí, E. S., & Chacón, P. (2014). iMODS: Internal coordinates normal mode analysis server. Nucleic Acids Research, 42(W1), W271–276. doi:10.1093/nar/gku339
  • Lopéz-Blanco, J. R., Garzón, J. I., & Chacón, P. (2011). iMod: Multipurpose normal mode analysis in internal coordinates. Bioinformatics, 27(20), 2843–2850. doi:10.1093/bioinformatics/btr497
  • Molecular Operating Environment (MOE). (2013). Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910,. Montreal, QC, Canada, H3A 2R7, (2014).
  • Muegge, I., Heald, S. L., & Brittelli, D. (2001). Simple selection criteria for drug-like chemical matter. Journal of Medicinal Chemistry, 44(12), 1841–1846. doi:10.1021/jm015507e
  • Muralidharan, N., Sakthivel, R., Velmurugan, D., & Michael Gromiha, M. (2020). Computational studies of drug repurposing and synergism of lopinavir,oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics. doi:10.1080/07391102.2020.1752802
  • Narayana, C., Somayajulu, B. A. R., & Thirumala, S. D. (1967). Recovery of fatty oil from spent seeds of Ajowan. Trachyspermum Ammi Linn.). Indian Journal of Technology, 5, 268–269.
  • Pant, S., Singh, M., Ravichandiran, V., Murty, U. S. N., & Srivastava, H. (2020). Peptide-like and small-molecule inhibitors against Covid-19Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.1757510
  • Pole, S. (2013). Ayurvedic medicine the principles of traditional practice, edited by S. Dragon, pp. 122–123.
  • Prabhakar, P. K., Srivastava, A., Rao, K. K., & Balaji, P. V. (2016). Monomerization alters the dynamics of the lid region in Campylobacter jejuni CstII: An MD simulation study. Journal of Biomolecular Structure and Dynamics, 34(4), 778–791. doi:10.1080/07391102.2015.1054430
  • Quezel, P., & Santa, S. (1963). Nouvelle flore de l’Algérie et des régions désertiques méridoniales. Tome II. CNRS, pp. 671.
  • Sahin, S., & Benet, L. Z. (2008). The operational multiple dosing half-life: A key to defining drug accumulation in patients and to designing extended release dosage forms. Pharmaceutical Research, 25(12), 2869–2877. doi:10.1007/s11095-008-9787-9
  • Sandberg, F., & Corrigon, D. (2001). Natural remedies, their origins and uses. Taylor & Francis.
  • Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995). A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel. Cell, 81(2), 299–307. doi:10.1016/0092-8674(95)90340-2
  • Sarma, P., Sekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Prasad Dhibar, D., & Medhi, B. (2020). In-silico homology assisted identificationof inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2020.1753580
  • Schirner, M. (2004). Huiles essentielles: Description de plus de 200 huiles essentielles et huiles végétales. Guy Trédaniel, 23.
  • Shang, J., Ye, G., Shi, K., Wan, Y. S., Luo, C. M., Aihara, H., Geng, Q. B., Auerbach, A., & Li, F. (2020). National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS).
  • Simon, L., Imane, A., Srinivasan, K. K., Pathak, L., & Daoud, I. (2017). In silico drug-designing studies on flavanoids as anticolon cancer agents: Pharmacophore mapping, molecular docking, and Monte Carlo method-based QSAR Modeling. Interdisciplinary Sciences: Computational Life Sciences, 9(3), 445–458. doi:10.1007/s12539-016-0169-4
  • Smalling, R. W. (1996). Molecular biology of plasminogen activators: What are the clinical implications of drug design? The American Journal of Cardiology, 78(12A), 2–7. doi:10.1016/s0002-9149(96)00736-9
  • Stewart, J. J. (2007). Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements. Journal of Molecular Modeling, 13(12), 1173–1213. doi:10.1007/s00894-007-0233-4
  • Swierczewska, M., Lee, K. C., & Lee, S. (2015). What is the future of PEGylated therapies. Expert Opinion on Emerging Drugs, 20(4), 531–536. doi:10.1517/14728214.2015.1113254
  • Trabut, L. (1935a). Flore du Nord de l’Afrique: Répertoire des noms indigènes des plantes spontanées, cultivées et utilisées dans le Nord de l’Afrique. Collection du Centenaire de l’Algérie, Alger.
  • Trabut, L. C. (1935b). Répertoire des noms indigènes des plantes spontanées, cultivées et utilisées dans le nord de l’Afrique. Alger. (Collection du centenaire de l’Algérie. Flore du nord de l’Afrique), 355.
  • Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. doi:10.1021/jm020017n
  • Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical Medicine & International Health, 278–280.
  • Zaretzki, J., Bergeron, C., Huang, T-w., Rydberg, P., Swamidass, S. J., & Breneman, C. M. (2013). RS-WebPredictor: A server for predicting CYP-mediated sites of metabolism on drug-like molecules. Bioinformatics, 29(4), 497–498. doi:10.1093/bioinformatics/bts705

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.